FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012666847> ?p ?o ?g. }

• W2012666847 endingPage "579" @default.
• W2012666847 startingPage "573" @default.
• W2012666847 abstract "Within five years of discovering endothelin (ET-1) in 1988, the first report of an orally available ET receptor antagonist was published. Within twelve years, bosentan, the first ET receptor antagonist to gain marketing authorisation, was made available for the treatment of pulmonary artery hypertension (PAH). Since this milestone in ET biology, several ET receptor antagonists have been developed, principally to target cardiovascular disease states. ET-1 acts through two receptors – ETA and ETB. Currently, the mixed antagonist, bosentan, and the selective ETA antagonist, sitaxsentan, are both licensed for the treatment of PAH, and clinical trials with these and other agents are ongoing for many diseases, including scleroderma, diabetic nephropathy and prostate cancer. Although there has been no argument about the importance of blocking ETA receptors, there remains a long-running debate as to whether additional ETB antagonism is of benefit, and this is the topic of the following review. Within five years of discovering endothelin (ET-1) in 1988, the first report of an orally available ET receptor antagonist was published. Within twelve years, bosentan, the first ET receptor antagonist to gain marketing authorisation, was made available for the treatment of pulmonary artery hypertension (PAH). Since this milestone in ET biology, several ET receptor antagonists have been developed, principally to target cardiovascular disease states. ET-1 acts through two receptors – ETA and ETB. Currently, the mixed antagonist, bosentan, and the selective ETA antagonist, sitaxsentan, are both licensed for the treatment of PAH, and clinical trials with these and other agents are ongoing for many diseases, including scleroderma, diabetic nephropathy and prostate cancer. Although there has been no argument about the importance of blocking ETA receptors, there remains a long-running debate as to whether additional ETB antagonism is of benefit, and this is the topic of the following review." @default.
• W2012666847 created "2016-06-24" @default.
• W2012666847 creator A5046696016 @default.
• W2012666847 creator A5066047278 @default.
• W2012666847 creator A5081449769 @default.
• W2012666847 creator A5085998748 @default.
• W2012666847 date "2007-11-01" @default.
• W2012666847 modified "2023-09-27" @default.
• W2012666847 title "Selective and mixed endothelin receptor antagonism in cardiovascular disease" @default.
• W2012666847 cites W1754404124 @default.
• W2012666847 cites W1929084030 @default.
• W2012666847 cites W1976902114 @default.
• W2012666847 cites W1980138733 @default.
• W2012666847 cites W1982170386 @default.
• W2012666847 cites W1983312374 @default.
• W2012666847 cites W1990938332 @default.
• W2012666847 cites W1991622094 @default.
• W2012666847 cites W1991900778 @default.
• W2012666847 cites W1992109588 @default.
• W2012666847 cites W1996851962 @default.
• W2012666847 cites W1999517728 @default.
• W2012666847 cites W1999718652 @default.
• W2012666847 cites W2000620003 @default.
• W2012666847 cites W2001993227 @default.
• W2012666847 cites W2003591994 @default.
• W2012666847 cites W2005408453 @default.
• W2012666847 cites W2011351479 @default.
• W2012666847 cites W2013616551 @default.
• W2012666847 cites W2021191584 @default.
• W2012666847 cites W2025990454 @default.
• W2012666847 cites W2026218999 @default.
• W2012666847 cites W2029969503 @default.
• W2012666847 cites W2030190730 @default.
• W2012666847 cites W2036446038 @default.
• W2012666847 cites W2048443661 @default.
• W2012666847 cites W2054833206 @default.
• W2012666847 cites W2061837563 @default.
• W2012666847 cites W2074636215 @default.
• W2012666847 cites W2074996906 @default.
• W2012666847 cites W2091508721 @default.
• W2012666847 cites W2092456220 @default.
• W2012666847 cites W2093034906 @default.
• W2012666847 cites W2093984243 @default.
• W2012666847 cites W2097485120 @default.
• W2012666847 cites W2101535700 @default.
• W2012666847 cites W2104413112 @default.
• W2012666847 cites W2104840130 @default.
• W2012666847 cites W2105570450 @default.
• W2012666847 cites W2107603188 @default.
• W2012666847 cites W2114778001 @default.
• W2012666847 cites W2115236627 @default.
• W2012666847 cites W2115374185 @default.
• W2012666847 cites W2116615883 @default.
• W2012666847 cites W2117259028 @default.
• W2012666847 cites W2126370870 @default.
• W2012666847 cites W2138091764 @default.
• W2012666847 cites W2141987653 @default.
• W2012666847 cites W2150810615 @default.
• W2012666847 cites W2151728747 @default.
• W2012666847 cites W2154315205 @default.
• W2012666847 cites W2160257210 @default.
• W2012666847 cites W2162804111 @default.
• W2012666847 cites W2163096271 @default.
• W2012666847 cites W2163370089 @default.
• W2012666847 cites W2166811364 @default.
• W2012666847 cites W2170073073 @default.
• W2012666847 cites W2181604783 @default.
• W2012666847 cites W2188647398 @default.
• W2012666847 cites W2298101895 @default.
• W2012666847 cites W2315254400 @default.
• W2012666847 cites W2319611369 @default.
• W2012666847 cites W2321440587 @default.
• W2012666847 cites W2334817595 @default.
• W2012666847 cites W2336346210 @default.
• W2012666847 cites W2338036527 @default.
• W2012666847 cites W2385448239 @default.
• W2012666847 cites W2411195788 @default.
• W2012666847 cites W2414047451 @default.
• W2012666847 cites W3141289570 @default.
• W2012666847 doi "https://doi.org/10.1016/j.tips.2007.10.002" @default.
• W2012666847 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17950470" @default.
• W2012666847 hasPublicationYear "2007" @default.
• W2012666847 type Work @default.
• W2012666847 sameAs 2012666847 @default.
• W2012666847 citedByCount "66" @default.
• W2012666847 countsByYear W20126668472012 @default.
• W2012666847 countsByYear W20126668472013 @default.
• W2012666847 countsByYear W20126668472014 @default.
• W2012666847 countsByYear W20126668472015 @default.
• W2012666847 countsByYear W20126668472016 @default.
• W2012666847 countsByYear W20126668472017 @default.
• W2012666847 countsByYear W20126668472018 @default.
• W2012666847 countsByYear W20126668472020 @default.
• W2012666847 countsByYear W20126668472022 @default.
• W2012666847 crossrefType "journal-article" @default.
• W2012666847 hasAuthorship W2012666847A5046696016 @default.
• W2012666847 hasAuthorship W2012666847A5066047278 @default.
• W2012666847 hasAuthorship W2012666847A5081449769 @default.

• next